Newsfiscal.ai
C4 Therapeutics Initiated at Buy by Lake Street
· Published
Article summary
Lake Street Capital Markets has initiated coverage of C4 Therapeutics with a Buy rating.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…